Show simple item record

The Effect of Ciprofloxacin on the Pharmacokinetic and ECG Parameters of Quinidine

dc.contributor.authorBleske, Barry E.en_US
dc.contributor.authorCarver, Peggy L.en_US
dc.contributor.authorAnnesley, Thomas M.en_US
dc.contributor.authorBleske, Jane R. M.en_US
dc.contributor.authorMorady, Freden_US
dc.date.accessioned2013-04-08T20:49:34Z
dc.date.available2013-04-08T20:49:34Z
dc.date.issued1990-10en_US
dc.identifier.citationBleske, Barry E.; Carver, Peggy L.; Annesley, Thomas M.; Bleske, Jane R. M.; Morady, Fred (1990). "The Effect of Ciprofloxacin on the Pharmacokinetic and ECG Parameters of Quinidine." The Journal of Clinical Pharmacology 30(10). <http://hdl.handle.net/2027.42/97168>en_US
dc.identifier.issn0091-2700en_US
dc.identifier.issn1552-4604en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/97168
dc.publisherBlackwell Publishing Ltden_US
dc.publisherWiley Periodicals, Inc.en_US
dc.titleThe Effect of Ciprofloxacin on the Pharmacokinetic and ECG Parameters of Quinidineen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelPharmacy and Pharmacologyen_US
dc.subject.hlbsecondlevelPediatricsen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumUniversity of Michigan, College of Pharmacyen_US
dc.contributor.affiliationumUniversity of Michigan Medical Center Departments of Pharmacyen_US
dc.contributor.affiliationotherInternal Medicineen_US
dc.contributor.affiliationotherPathologyen_US
dc.identifier.pmid2229451en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/97168/1/j.1552-4604.1990.tb03570.x.pdf
dc.identifier.doi10.1002/j.1552-4604.1990.tb03570.xen_US
dc.identifier.sourceThe Journal of Clinical Pharmacologyen_US
dc.identifier.citedreferenceTartaglione TA, Raffalovich AC, Poynor WJ, Espinel‐Ingroff A, Kerkering TM: Pharmacokinetics and tolerance of ciprofloxacin after sequential increasing oral doses. Antimicrob Agents Chemother 1986; 29: 62 – 66.en_US
dc.identifier.citedreferenceGau W, Kurz J, Petersen U, Ploschke HJ, Wuensche C: Isolation and structural elucidation of urinary metabolites of ciprofloxacin. Arzneim-Forsch/Drug Res 1986; 36 ( II ): 1545 – 1549.en_US
dc.identifier.citedreferenceWijnands WJA, Vree TB, van Herwaarden CLA: The influence of quinolone derivatives on theophylline clearance. Br J Clin Pharmacol 1986; 22: 677 – 683.en_US
dc.identifier.citedreferenceNix DE, DeVito JM, Whitbread MA, Schentag JJ: Effect of multiple dose oral ciprofloxacin on the pharmacokinetics of theophylline and indocyanine green. J Antimicrob Chemother 1987; 19: 263 – 269.en_US
dc.identifier.citedreferencePrince RA, Casabar E, Adair CG, Wexler DB, Lettieri J, Kasik JE: Effect of quinolone antimicrobials on theophylline pharmacokinetics. J Clin Pharmacol 1989; 29: 650 – 654.en_US
dc.identifier.citedreferenceLudwig E, Szekely E, Csiba A, Graber H: The effect of ciprofloxacin on antipyrine metabolism. J Antimicrob Chemother 1988; 22: 61 – 67.en_US
dc.identifier.citedreferenceHealy DP, Polk RE, Kanawati L, Rock DT, Mooney ML: Interaction between oral ciprofloxacin and caffeine in normal volunteers. Antimicrob Agents Chemother 1989; 33: 474 – 478.en_US
dc.identifier.citedreferenceDrayer DE, Lowenthal DT, Restivo KM, Schwartz A, Cook CE, Reidenberg MM: Steady‐state serum levels of quinidine and active metabolites in cardiac patients with varying degrees of renal function. Clin Pharmacol Ther 1978; 24: 31 – 39.en_US
dc.identifier.citedreferenceUeda CT: Quinidine, In Evans WE, Schentag JJ, Jusko WJ, (Eds.): Applied Pharmacokinetics: Principles of Therapeutic Drug Monitoring. Spokane, Applied Therapeutics, Inc., 1986; 000 – 000.en_US
dc.identifier.citedreferenceHardy BG, Zador IT, Golden L, Lalka D, Schentag JJ: Effect of cimetidine on the pharmacokinetics and pharmacodynamics of quinidine. Am J Cardiol 1983; 52: 172 – 175.en_US
dc.identifier.citedreferenceKessler KM, Humphries WC, Black M, Spann JF: Quinidine pharmacokinetics in patients with cirrhosis or receiving propranolol. Am Heart J 1978; 96: 627 – 635.en_US
dc.identifier.citedreferenceEdwards DJ, Lavoie R, Beckman H, Blevins R, Rubenfire M: The effect of coadministration of verapamil on the pharmacokinetics and metabolism of quinidine. Clin Pharmacol Ther 1987; 41: 68 – 73.en_US
dc.identifier.citedreferenceGreenblatt DJ, Franke K, Huffman DH: Impairment of antipyrine clearance in humans by propranolol. Circulation 1978; 57: 1161 – 1164.en_US
dc.identifier.citedreferenceBax NDS, Lennard MS, Tucker GT: Inhibition of antipyrine metabolism by beta‐adrenoceptor antagonists. Br J Clin Pharmacol 1981; 12: 779 – 784.en_US
dc.identifier.citedreferenceBach DR, Blevins R, Kerner N, Rubenfire M, Edwards DJ: The effect of verapamil on antipyrine pharmacokinetics and metabolism in man. Br J Clin Pharmacol 1986; 21: 655 – 659.en_US
dc.identifier.citedreferenceWolf‐Rogers JA, Smith CM, Vaughn K: Automated fluorescence polarization immunoassay for monitoring quinidine (abstr). Clin Chem 1984; 30: 1020.en_US
dc.identifier.citedreferenceChen BH, Taylor EH, Ackerman BH, Olsen K, Pappas AA: Effect of pH on free quinidine (letter). Drug Intell Clin Pharm 1988; 22: 826.en_US
dc.identifier.citedreferenceVerme CN, Ludden TM, Harris SC: Effect of temperature on in vitro measurement of quinidine free fraction. Clin Pharm 1988; 7: 142 – 146.en_US
dc.identifier.citedreferenceHoffken G, Lode H, Prinzing C, Borner K, Koeppe P: Pharmacokinetics of ciprofloxacin after oral and parenteral administration. Antimicrob Agents Chemother 1985; 27: 375 – 379.en_US
dc.identifier.citedreferenceVesell ES: Commentary. The antipyrine test in clinical pharmacology: Conceptions and misconceptions. Clin Pharmacol Ther 1979; 26: 275 – 286.en_US
dc.identifier.citedreferenceGuengerich FP, Muller‐Enoch D, Blair IA: Oxidation of quinidine by human liver cytochrome P‐450. Mol Pharmacol 1986; 30: 287 – 295.en_US
dc.identifier.citedreferenceWaite NM, Edwards DJ, Arnott WS, Warbasse LH: Effects of ciprofloxacin on testosterone and Cortisol concentrations in healthy males. Antimicrob Agents Chemother 1989; 33: 1875 – 1877.en_US
dc.identifier.citedreferenceHo G, Tierney MG, Dales RE: Evaluation of the effect of norfloxacin on the pharmacokinetics of theophylline. Clin Pharmacol Ther 1988; 44: 35 – 38.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.